“3D printing has begun to flourish in various application areas in healthcare such as dental, medical, implants, drug manufacturing and so on. The materials used for these purposes vary accordingly. While dental implants mostly use metals and ceramics to print dental crowns, the medical industry has its own array of bio-materials. As per IndustryARC analysis, the 3DP materials in healthcare market has revenue of $284.7 million as of 2014, and is estimated to grow at a CAGR of 19.1% over the next 6 years.
Reduction in prices of printers in healthcare 3D printing is estimated due to the growing demand and possible subsidies from governments as part of research grants as well. The commonly used materials for 3D printing of healthcare are plastics, metals, ceramics, donor cells, bone cement, biomaterials etc. Metal powders and biomaterials are expensive, wherein biomaterials are under research stage and are expected to be a prominent material for the 3D printing in healthcare industry. The global 3D printing in healthcare market recorded revenue of $487m in 2014 and is estimated to grow at a CAGR of 18.3% till 2020. The high growth rate in this market is due to increasing adaptation of 3D printing technologies into healthcare. This increasing adoption is due to wide spectrum of 3D printing applications in healthcare. The market is set to be driven by the increasing demand for patient-specific tailored products in orthopedics and maxillofacial surgery. Advances in tissue engineering for 3D bio-printing is gaining importance and the tissues generated by bio-printing will be available for transplant in the near future. However, high costs and regulatory barriers are likely to hinder the market growth.
North America is the leading consumer of 3D printing in healthcare industry, followed by Europe. Asia-Pacific’s (APAC’s) market is relatively small as compared to Americas region; however it is growing at a higher rate compared to Americas. With respect to the global market, the US itself holds 39.7% of the entire 3D printing in healthcare market share with existing major players like 3D Systems and Stratasys along with the new entrants and their investments to acquire the growing market. Europe is the second major market followed by APAC, together accounting for around 37% of the global 3D printing in healthcare market of 2014. Other factors affecting the growth of the market include technology innovation, efficiency and flexibility of printers and availability of good quality materials.
In this report, the market has been segmented by geography as America, Europe, Asia, and Rest of the World (RoW). Market size and forecast is provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the 3DP materials, printers, software and scanners market and future opportunities are provided in the report.
Key players covered in the market landscape analysis section are:
Digilab
EnvisionTEC
Invetech
MicroFab Technologies
nScrypt
Tevido BioDevices.”
“1. Executive Summary
2. Global 3D Printing in Healthcare – Market Overview
2.1. Introduction
2.2. Stakeholders
3. Market Landscape
3.1. Market Player Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
4. 3D Printing in Healthcare Market – Market Forces
4.1. Market Drivers
4.1.1. Increasing Demand for Implants in the Health Care Industry
4.1.2. Increased Investments in R&D from New Entrants Due To Growing Adaption of 3D Printing Technology
4.2. Market Constraints
4.2.1. High Costs of Printers and Limited Types of Materials Are Accessible By a Printer
4.3. Market Challenge
4.3.1. Sustainability of New Entrants
4.3.2. 3D Printing Of Organ Implants and Drug Synthesis
4.4. Attractiveness of the 3D Printing in Healthcare
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Global 3d Printing in Healthcare Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.2.1. 3DP Materials
5.2.2. 3D Printers in Healthcare
5.3. Opportunities Analysis
5.3.1. Evolution in 3D Printing (3DP) Materials Market
5.3.2. Innovations in 3D Printed Organs
5.4. Opportunities Analysis
5.4.1. Evolution in 3d Printing (3DP) Materials Market
5.4.2. Innovations in 3D Printed Organs
5.5. Market Life Cycle Analysis
5.6. Supplier and Distributor Analysis
6. Global 3D Printing in Healthcare Market – By Technology
6.1. Introduction
6.2. Laser Beam Melting (LBM)
6.3. Electron Beam Melting (EBM)
6.4. Stereo Lithography
6.5. Photo Polymerization
6.6. Droplet Deposition
6.7. Laminated Object Manufacturing
6.8. Wax Deposition Modeling
6.9. Bio Printing
7. Global 3D Printing in Healthcare Market – By Material
7.1. Donor Cells
7.2. Plastics
7.3. Metals
7.4. Ceramics
7.5. Bone Cement
7.6. Others
8. Global 3D Printing in Healthcare Market – By Application
8.1. Introduction
8.1.1. Rising Implants and Surgeries Create Demand for 3D Printing
8.2. Implants and Prosthetics
8.3. Surgical Guides
8.4. Hearing Aids
8.5. Tissue Engineering
8.6. Dental Implants
8.7. Medical Components
8.8. Drug Screening
9. By Geography
9.1. Introduction
9.2. Americas
9.2.1. U.S
9.2.2. Canada
9.2.3. Brazil
9.3. Europe
9.3.1. U.K
9.3.2. Germany
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Australia
9.5. Rest of World
10. Company Profiles
10.1. Javelin Technologies Inc.
10.2. Medical Modeling Inc.
10.3. Nano3D Biosciences Inc.
10.4. Tissue Regeneration Systems Inc.
10.5. Xilloc Medical
10.6. 3D Biotek Llc.
10.7. 3T RPD Ltd.
10.8. Alphaform Ag
10.9. Organovo Holdings Inc.
10.10. Beltone A/S
10.11. Gyrobot Limited
10.12. Stryker Corporation
10.13. 3D Systems
10.14. Stratasys Ltd.
10.15. Arcam
10.16. Envisiontec Gmbh
10.17. EOS GMBH Electro Optical Systems
10.18. Materialise N.V.
10.19. Oxford Performance Materials
10.20. Tethon 3D
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
“”*Financials would be provided on a best efforts basis for private companies”””
“10.1. Javelin Technologies Inc.
10.2. Medical Modeling Inc.
10.3. Nano3D Biosciences Inc.
10.4. Tissue Regeneration Systems Inc.
10.5. Xilloc Medical
10.6. 3D Biotek Llc.
10.7. 3T RPD Ltd.
10.8. Alphaform Ag
10.9. Organovo Holdings Inc.
10.10. Beltone A/S
10.11. Gyrobot Limited
10.12. Stryker Corporation
10.13. 3D Systems
10.14. Stratasys Ltd.
10.15. Arcam
10.16. Envisiontec Gmbh
10.17. EOS GMBH Electro Optical Systems
10.18. Materialise N.V.
10.19. Oxford Performance Materials
10.20. Tethon 3D “
